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Background: Small airway fibrosis is the main contributor in airflow obstruction in chronic 
obstructive pulmonary disease. Epithelial mesenchymal transition (EMT) has been implicated 
in this process, and in large airways, is associated with angiogenesis, ie, Type-3, which is clas-
sically promalignant.
Objective: In this study we have investigated whether EMT biomarkers are expressed in small 
airways compared to large airways in subjects with chronic airflow limitation (CAL) and what 
type of EMT is present on the basis of vascularity.
Methods: We evaluated epithelial activation, reticular basement membrane fragmentation 
(core structural EMT marker) and EMT-related mesenchymal biomarkers in small and large 
airways from resected lung tissue from 18 lung cancer patients with CAL and 9 normal controls. 
Tissues were immunostained for epidermal growth factor receptor (EGFR; epithelial activation 
marker), vimentin (mesenchymal marker), and S100A4 (fibroblast epitope). Type-IV collagen 
was stained to demonstrate vessels.
Results: There was increased expression of EMT-related markers in CAL small airways 
compared to controls: EGFR (P,0.001), vimentin (P,0.001), S100A4 (P,0.001), and 
fragmentation (P,0.001), but this was less than that in large airways. Notably, there was no 
hypervascularity in small airway reticular basement membrane as in large airways. Epithelial 
activation and S100A4 expression were related to airflow obstruction.
Conclusion: EMT is active in small airways, but less so than in large airways in CAL, and 
may be relevant to the key pathologies of chronic obstructive pulmonary disease, small airway 
fibrosis, and airway cancers.
Keywords: EMT, EGFR, S100A4, vimentin, fragmentation, small airways
Background
Chronic obstructive pulmonary disease (COPD) is a huge global health problem.1 As 
its core is progressive narrowing of the airways caused by noxious particles and gases 
particularly from cigarette smoke.2 COPD airway remodeling changes are mostly 
related to reduced airflow due to small airway fibrosis, and ultimately, obliteration.3 
Emphysema is a later variable secondary phenomenon.4
Recent observations have emphasized reticular basement membrane (Rbm) frag-
mentation, cellularity, and hypervascularity in large-airway biopsies from smokers 
and COPD patients.5–7 There is limited evidence that epithelial mesenchymal transi-
tion (EMT) is also active in small airways.8,9 Angiogenesis in the Rbm is specifically 
smoking related,10,11 while other features are most marked in COPD.5
In EMT, epithelial cells transition into a mesenchymal phenotype with subsequent 
migration into the underlying lamina propria and may be associated with accumulation 
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of myofibroblasts immediately adjacent to the lamina propria. 
EMT has been implicated in tissue fibrosis12 in the so-called 
Type-2 form and when associated with hypervascularity 
(Type-3) with epithelial cancers development.13
COPD itself is a major risk factor for lung cancer.14,15 
It is notable that epithelial cancers make up approximately 
90% of all human malignancies, suggesting that epithelial 
cells are especially unstable and EMT-associated mecha-
nisms may be the common factor. Local tissue angiogenesis 
is especially regarded as another key aspect of both the 
premalignant and malignant phases of epithelial cancer 
development.16
Our previous published work used large-airway endo-
scopic biopsies.7 The present study was designed to compare 
the degree of EMT activity in small versus matching large 
airways and also type of EMT in each compartment, using 
lung tissue resected from smokers undergoing lung resection 
for lung cancer. We also wished to explore the relationship 
between epithelial and EMT activity and the degree of airflow 
obstruction in this group selected to have a wide variation in 
chronic airflow limitation (CAL).
Materials and methods
study design
The Tasmanian health and medical Human Research 
Ethics Committee approved this study (#EC00337). All 
subjects gave written, informed consent prior to partici-
pation.
Eighteen patients with CAL were included. All had pri-
mary non small cell lung cancer and an approximately equal 
mix of squamous and adenocarcinoma, and were smokers. 
Nine patients had demonstrated stage 1 or 2 COPD17 on 
spirometry (forced expiratory ratio ,70%), and nine patients 
had small airway disease only with scalloping of the expi-
ratory limb of the flow–volume curve (forced expiratory 
flow
25–75
 ,68% predicted). By selection, there was no history 
of other chronic respiratory disorders.
Sections from nine normal nonsmoker subjects (normal 
control [NC]) were included as a control group for small 
airways data and were provided from the bio bank at the 
University of British Columbia.
study samples
Surgical resection material containing noncancer affected 
small and large airways were fixed in formalin within minutes 
of surgery. At processing, tissue blocks of large and small 
airways (,2.5 mm internal diameter)18 were separately 
embedded in paraffin for our analyses.
Immunostaining
Serial sections of resected tissue were immunostained 
for EMT mesenchymal biomarkers (S100A4, Vimentin), 
for the epithelial activation marker (epidermal growth 
factor receptor [EGFR]) and for vascularity using anti-
Type-IV collagen for vessels in the Rbm. Sections of 3-µm 
thickness were mounted and stained with hematoxylin and 
eosin for morphological assessment and suitability for 
immunostaining. At room temperature, optimal sections 
were stained with the following antibodies: polyclonal 
anti-S100A4 (Dako, catalog no A5114, at 1:2,000 for 
90 minutes), antivimentin monoclonal antibody (Dako, 
catalog no M7020, at 1:1,000 for 60 minutes), and Type-IV 
collagen monoclonal antibody (Dako, catalog no M0785, at 
1:100 for 90 minutes) and monoclonal anti-EGFR (Dako, 
catalog no M3563, at 1:1,000 for 90 minutes). In each 
run, a section stained with immunoglobulin G1-negative 
control (X0931 clone DAKGO1; Dako Cytomation) was 
included to ensure absence of false-positive staining. 
Bound antibodies were elaborated by using horseradish 
peroxidase-conjugated DAKO Envision plus reagent 
(catalog no K4001, anti-mouse or K4003 anti-rabbit) and 
diaminobenzidine for a brown color resolution (catalog no 
K3468; Dako Cytomation). We have extensively used and 
published these methods.5,6,19,20
Tissue section analysis and quantitation
Computer-assisted image analysis was performed by 
using microscopy at 40× magnification (Leica DM 2500, 
Microsystems, Germany), a Spot insight 12 digital camera 
(Spot Imaging, MI, USA) and Image Pro V5.1 software 
(Media Cybernetics, Rockville, MD, USA). We randomly 
choose eight good fields for both large and small airways 
without a tumor interface, from each lung resection, for 
each of the biomarkers. We quantified the degree of Rbm 
fragmentation by measuring the length of linear clefts and 
expressed it as a percentage of total Rbm length. Slides 
were randomly mingled, coded, and assessed blind. All 
slides were quantified for epithelial activation (EGFR) and 
EMT biomarkers, ie, fragmentation, S100A4, vimentin, 
and vascularity (Type-IV collagen) in both large and small 
airways, in a single batch by an experienced observer 
(MQM). Quality assurance was provided by a professional 
academic pathologist (HKM).
EGFR was quantitated as a percentage of epithelial area 
stained while the EMT biomarkers (S100A4, vimentin) were 
quantitated as the number of basal cells in epithelium and 
cells in Rbm per millimeter of Rbm.
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statistical analysis
Large airways have previously been assessed against nor-
mal smokers and nonsmoking controls5 and that was not 
repeated. Current data for large and small airways in CAL 
were compared against each other, and then for small airways 
against NCs.
Because the data were normally distributed, results for 
each marker are presented as mean and 95% confidence 
interval (CI). Comparisons between different markers in 
large versus small airways, and small airways, normal 
versus CAL, used paired t-test. Associations between vari-
ables were assessed using Pearson’s rank test. Statistical 
analyses were performed using SPSS (statistics version 
20.0; IBM Corporation, Armonk, NY, USA) for Windows 
7.0 and a P-value of #0.05 was considered statistically 
significant.
Results
The overall demographics of two groups are presented in 
Table 1 and results in Tables 2 and 3.
egFr expression in epithelium
A greater proportion of the airway epithelium stained for 
EGFR in large airways of CAL patients (mean 11.4%, CI 
9.9–12.8) (Figure 1) compared to CAL small airways (mean 
6.8%, CI 5.5–8.1) (P,0.001) (Figure 2). There was also a 
marked difference between small airways in the CAL group 
and the normal small airways (mean 0.6%, CI 0.3–0.8) 
(P,0.001) (Figure 3).
Fragmentation in the rbm
Fragmentation of the Rbm was more marked in large 
airways from CAL subjects (mean 27.9%, CI 24.3–31.6) 
(Figure 4) than in their small airways (mean 14.9%, CI 
13–16.9) (P,0.001) (Figure 2). Small airways from CAL 
subjects showed significantly greater fragmentation than 
normal small airways (mean 2.4%, CI 2.1–2.7) (P,0.001) 
(Figure 3).
s100a4- and vimentin-positive cells 
in the basal epithelium
We observed S100A4 and vimentin staining in the basal 
layer of the epithelium in both large and small airways 
in CAL, but with considerably more marked expression 
in large airways (P,0.001 for each) (Figure 4) (S100A4, 
mean 42.9 cells/mm3, CI 38.5–47.4; vimentin, mean 
69.7 cells/mm3, CI 60.1–79.3) than in small airways 
(S100A4, mean 25.9 cells/mm3, CI 22.8–28.9; vimentin, 
mean 41.5 cells/mm3, CI 35.8–47.4) (Figures 5 and 6). 
In turn there was significantly greater expression in CAL 
small airways than in NC small airways (S100A4, mean 
6.4 cells/mm3, CI 4.7–7.9; vimentin, mean 8.2 cells/mm3, 
CI 6.9–9.4) (for both P,0.001) (Figure 7).
s100a4- and vimentin-positive cells 
in the rbm
In comparison to CAL large airways (S100A4, mean 
24.1 cell/mm3, CI 22.2–25.9; vimentin, mean 36.1 cells/mm3, 
CI 32.8–39.5) (Figure 4), there was a slight but significant 
low expression of these mesenchymal markers in small 
airways (S100A4, mean 13.9 cells/mm3, CI 12.5–15.3; 
Table 1 Demographic detail and lung function data of Cal 
patients and control subjects
Groups (numbers) CAL (n=18) Normal (n=9)
Male/female 13/5 6/3
age (years) 64 (58.7–69.2) 52 (42.4–63.3)
smoking pack years (range) 39 (24.1–40.1) n/a
FeV1% predicted 82 (76–89.4) n/a
FeV/FVC% (range) 69 (66.9–73.1) n/a
FeF25–75% predicted 48.5 (39.9–57.1) n/a
Note: Data expressed as mean and 95% confidence interval.
Abbreviations: CAL, chronic airflow limitation; FEF, forced expiratory flow; FEV1, 
forced expiratory volume in 1 second; FVC, forced vital capacity; n/a, not applicable.
Table 2 Comparison of different pathological indices in Cal large and small airways
Indices Large airway
(CAL)
Small airway
(CAL)
Mean difference
(95% CI)
Small airway
(normal control)
s100a4 (epithelium) 42.9 (38.5–47.4) 25.9 (22.8–28.9) 17 (11.4–22.6) P,0.001 6.4 (4.7–7.9) P,0.001
s100a4 (rbm) 24.1 (22.2–25.9) 13.9 (12.5–15.3) 10.2 (7.7–12.6) P,0.001 5.3 (4.1–6.5) P,0.001
Vimentin (epithelium) 69.7 (60.1–79.3) 41.5 (35.8–47.4) 28.2 (16.5–39.8) P,0.001 8.2 (6.9–9.4) P,0.001
Vimentin (rbm) 36.1 (32.8–39.5) 27.8 (25.4–30.2) 8.3 (4.1–12.6) P,0.001 8.1 (6.7–9.5) P,0.001
Fragmentation (rbm) 27.9 (24.3–31.6) 14.9 (13–16.9) 13 (8.72–17.26) P,0.001 2.4 (2.1–2.7) P,0.001
Vessels (rbm) 8.5 (7.6–9.4) 0.2 (0.05–0.3) 8.3 (7.4–9.1) P,0.001 0.05 (0.02–0.13) P= ns
egFr (epithelium) 11.4 (9.9–12.8) 6.8 (5.5–8.1) 4.6 (2.6–6.5) P,0.001 0.6 (0.3–0.8) P,0.001
Note: Data expressed as mean and 95% CI.
Abbreviations: CAL, chronic airflow limitation; CI, confidence interval; EGFR, epidermal growth factor receptor; Rbm, reticular basement membrane; NS, not significant.
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vimentin, mean 27.8 cells/mm3, CI 25.4–30.2) (for both 
P,0.001) (Figures 5 and 6). However, once again, expres-
sion was greater in the small airways in CAL compared 
to NC small airways (S100A4, mean 5.3 cells/mm3, CI 
4.1–6.5; vimentin, mean 8.1 cells/mm3, CI 6.7–9.5) (for both 
P,0.001) (Figure 7).
Blood vessels in the rbm
Hypervascularity of the Rbm was found only in CAL large 
airways (mean 8.5 vessels per millimeter of Rbm, CI 7.6–9.4) 
(Figure 4) and not in the small airways either in CAL (mean 
0.2 vessels per millimeter of Rbm, CI 0.05–0.3) (P,0.001) 
or the control group (mean 0.05 vessels per millimeter of 
Rbm, CI 0.02–0.13) (P= not significant) (Figure 7 and 8).
regression data
In CAL subjects, there were significant relationships between 
increasing airflow obstruction and increasing epithelial 
activation (EGFR expression) and enhanced S100A4 expres-
sion in both epithelial basal cells and in Rbm cells, generally 
most marked for small airways pathology and for small 
airway obstruction (forced expiratory flow
25–75
% predicted) 
(Figure 9). There was quite a dichotomy between these 
relationships and the absence of such relationships for Rbm 
fragmentation and vimentin expression (Table 4).
Discussion
This study sought to analyze the expression of classic 
EMT structural and mesenchymal biomarkers, epithelial 
activation, and also vascular changes, in matching large 
and small airways from smoking patients with airflow 
obstruction (CAL). We have previously demonstrated that 
in large-airway biopsies from smokers compared to NC 
tissue, epithelial activation, EMT biomarkers, and related 
classic structural changes are highly expressed and that 
these changes are greatest in those with COPD.5 Here we 
show that small airways from a group of CAL patients also 
demonstrated active EMT significantly above normal, but 
uniformly less so than in large airway. However, in small air-
ways, EMT changes are not associated with hypervascularity, 
ie, could be considered as the profibrotic Type-2 EMT rather 
than the more malignancy-associated Type-3 EMT.
In both large and small airways in this CAL group, stain-
ing for S100A4 and vimentin was focused in the basal cell 
layer of the epithelium. This may highlight the likelihood of 
these cells being especially involved in undergoing transition 
to a mesenchymal phenotype. Similar positive staining of 
cells in the clefts of the disrupted Rbm further strengthens this 
concept of transition and migration of these basal cells. We 
have previously shown that the Rbm cells are not immune or 
inflammatory cells and that they do strongly express matrix 
Table 3 Comparison of different pathological indices in Cal small airway and normal control small airway
Indices Small airway  
(CAL)
Small airway  
(normal control)
Mean difference  
(95% CI)
s100a4 (epithelium) 25.9 (22.8–28.9) 6.4 (4.7–7.9) 19.5 (12.7–26.5) P,0.001
s100a4 (rbm) 13.9 (12.5–15.3) 5.3 (4.1–6.5) 8.6 (5.6–11.6) P,0.001
Vimentin (epithelium) 41.5 (35.8–47.4) 8.2 (6.9–9.4) 33.3 (19.1–47.6) P,0.001
Vimentin (rbm) 27.8 (25.4–30.2) 8.1 (6.7–9.5) 19.7 (14.5–24.9) P,0.001
Fragmentation (rbm) 14.9 (13–16.9) 2.4 (2.1–2.7) 12.5 (7.3–17.8) P,0.001
Vessels (rbm) 0.2 (0.05–0.3) 0.05 (0.02–0.13) 0.1 (−1–1.2) P= ns
egFr (epithelium) 6.8 (5.5–8.1) 0.6 (0.3–0.8) 6.2 (3.8–8.6) P,0.001
Note: Data expressed as mean and 95% CI.
Abbreviations: CAL, chronic airflow limitation; CI, confidence interval; EGFR, epidermal growth factor receptor; Rbm, reticular basement membrane; NS, not significant.
(*)5
/DUJHDLUZD\
Figure 1 large airway tissue from patient with Cal.
Notes: Black arrows indicate large-airway epithelium (chronic airflow limitation) 
stained positive for EGFR (epithelial activation marker). Original magnification, ×360. 
scale bar =50 µm.
Abbreviations: CAL, chronic airflow limitation; EGFR, epidermal growth factor 
receptor.
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metalloprotein-9, ie, with proteolytic capacity to digest their 
way through the lamina propria, thereby likely causing Rbm 
fragmentation.5,6
The differentiation into Type-2 EMT in small airways 
(,2 mm internal diameter) is consistent with fibrosis and 
obliteration here. Classically more cancer develops in large 
airways,18,21,22 especially for the squamous cell variety where 
Type-3 EMT predominates. Myofibroblast accumulation 
accompanies the damage to small airways in COPD.23 The 
origin of these myofibroblasts is not fully understood, but 
our data suggest that they might be derived from EMT. 
Endothelial mesenchymal transition, pericyte transformation, 
or stroma cells are other possible sources.24,25 Further work 
is needed to delineate these possibilities.
$  




 3
/DUJHDLUZD\ 6PDOODLUZD\ 1RUPDOVPDOODLUZD\ /DUJHDLUZD\ 6PDOODLUZD\ 1RUPDOVPDOODLUZD\
(*)
5H
[SU
HVV
LRQ
H
SLWK
HOLX
P
5
EP
IUDJ
PHQ
WDWLR
Q3 3
3




%
Figure 2 (A) Percentage of large-airway epithelium in Cal patients stained for egFr compared with Cal small airway and normal control small airway. (B) Percentage 
of rbm fragmentation (total length of clefts as percentage of the total length of rbm) in large airway in Cal patients versus Cal small airway and in normal control small 
airway.
Abbreviations: CAL, chronic airflow limitation; EGFR, epidermal growth factor receptor; Rbm, reticular basement membrane.
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Figure 3 Comparison of small airway in Cal subjects with normal control.
Notes: (A) Black arrows indicate epithelium stained positive for egFr only in Cal; (B) rbm fragmentation and cells contained in fragmented rbm (black arrows) only in 
CAL. Original magnification, ×360. scale bar =50 µm.
Abbreviations: CAL, chronic airflow limitation; EGFR, epidermal growth factor receptor; Rbm, reticular basement membrane.
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Figure 4 large-airway tissue from patient with Cal.
Notes: Black arrows indicate: (A) s100a4 and (B) vimentin-positive cells in epithelium and fragmented rbm; (C) Black arrows indicate hypervascularity of the rbm with 
Type-IV collagen-stained blood vessels in the rbm (Type-3 eMT). (D) Black arrows indicate fragmented Rbm-containing cells. Original magnification, ×360. scale bar =50 µm.
Abbreviations: CAL, chronic airflow limitation; EMT, epithelial mesenchymal transition; Rbm, reticular basement membrane.
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Figure 5 (A) Comparison of s100a4 expression in the (basal) epithelial cells of large airway in Cal patients, with small airway of Cal patients and normal control small 
airway. (B) Comparison of s100a4 expression in rbm of large airway in Cal patients with small airway of Cal patients and normal control small airway.
Abbreviations: CAL, chronic airflow limitation; Rbm, reticular basement membrane.
We have now shown that EMT is active in small airways 
and that at least S100A4 expression is associated with airflow 
obstruction, suggesting that this fibroblast marker may indeed 
be relevant to airway fibrosis. We are analyzing in detail 
the fibroblast subtypes and related changes in extracellular 
matrix. Interestingly, EMT is also thought to be involved 
in the development of idiopathic pulmonary fibrosis,26 and 
because this is also frequently smoking related, it suggests 
a certain pathological unity with the process in the small 
airways.
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Figure 6 (A) Comparison of number of basal epithelial cells positive for vimentin in Cal large airway versus Cal small airways and in normal control small airway. 
(B) Comparison of number of vimentin-positive cells in rbm in Cal large airway versus Cal small airway and normal control small airway.
Abbreviations: CAL, chronic airflow limitation; Rbm, reticular basement membrane.
Figure 7 small airway specimens from patients with Cal stained for eMT biomarkers and vascularity marker, compared with normal control small airway for comparison.
Notes: (A) s100a4 staining, black arrows indicate cells positive for s100a4 in rbm and basal epithelium; (B) staining with vimentin, black arrows indicate cells positive for 
vimentin in basal cells and in rbm; (C) Type-IV collagen-stained blood vessels. In small airway, vessels are seen only in lamina propria (black arrows) while rbm is devoid of 
vessels. Original magnification, ×360. scale bar =50 µm.
Abbreviations: CAL, chronic airflow limitation; EMT, epithelial mesenchymal transition; Rbm, reticular basement membrane.
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In agreement with our findings, Milara et al recently also 
observed upregulation of EMT biomarkers in small airways in 
COPD.9 Such EMT changes could also be induced in culture 
by cigarette smoke. Our study takes this further by quantifying 
Rbm structural changes, comparing large and small airways 
and characterizing Type-2 versus Type-3 EMT. Milara et al 
also implicated increasing cyclic adenosine monophosphate 
in EMT activity in the airways,27 while others implicated an 
urokinase plasminogen activator receptor-dependent signal-
ing pathway28 or a muscarinic mechanism.29
COPD is a major independent risk factor for the devel-
opment of non small cell lung cancer22 with squamous cell 
tumors developing in central airways and adenocarcinoma 
more in the peripheral airway tree. Multiple mechanisms 
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Figure 8 number of vessels in rbm in large airway of Cal compared with Cal 
small airway and normal control small airway.
Abbreviations: CAL, chronic airflow limitation; Rbm, reticular basement memb-
rane; NS, not significant.
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Figure 9 (A) Correlation between the number of small airway basal epithelial cells (per millimeter of rbm) that were positive for s100a4 with FeF25–75% (an index of small 
airway caliber). (B) Correlation between the number of s100a4-positive cells in rbm (per millimeter of rbm) in small airway and FeF25–75%. (C) Correlation between egFr 
(% epithelium) in small airway and FeF25–75%.
Abbreviations: EGFR, epidermal growth factor receptor; FEF, forced expiratory flow; Rbm, reticular basement membrane.
are associated with the development of malignancy includ-
ing genetic changes secondary to environmental insult 
(tobacco smoke) but it is also known that EMT, especially 
in association with hypervascularity, ie, Type-3, also has a 
strong procancerous influence.11,30 Thus, the local airway 
microenvironment is very important in carcinogenesis and 
metastasis.31 It is thought that vessels are immunoprotective 
through the expression of endocan, which inhibits the local 
antitumor activity of natural killer lymphocytes.32 It is also 
suggested that EMT gives rise to cancer-stimulating stromal 
cells (cancer-associated fibroblasts), which produce tumor-
enhancing growth factors.33
The main strength of this study is that we directly investi-
gated human tissue from CAL-affected individuals. Further, 
we have a fairly robust number of participants with good 
spread of airflow obstruction in large and small airways. 
Some limitations are, however, inevitable, especially the 
availability of NC small airway samples and international col-
laboration has been needed to provide this. We have focused 
on the empiric but classically described34 “downstream” 
phenotypic manifestation of EMT, ie, structural changes and 
protein expression. We will follow-up with detailed com-
parative analysis of more upstream pathways and expression 
of EMT-related transcription factors in large- versus small 
airway tissue and will perform molecular studies on both 
whole tissues and cell cultures.
Finally, due to the number of patients available to analyze, 
we have treated those with frank COPD (forced expiratory 
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airway eMT: large versus small bronchi
ratio ,70%) and those only with abnormal small airway 
function (scalloping of the expiratory limb of the volume 
loop and low forced expiratory flow
25–75
%) as a single group. 
The advantage that this gave us is that we had a wide range 
of physiological values for regression analyses, which have 
produced extremely interesting results. Our current group 
of cancer patients contained only four subjects without 
evidence of any airflow obstruction. Their details have not 
been included in this paper, although we will follow-up as 
numbers increase. It is interesting how relatively uncommon 
completely physiologically normal smoking cancer patients 
seem to be, but it is also noteworthy that they do seem to 
have EMT changes in both large and small airways, though 
less marked. Indeed, had their data been added to our regres-
sions, these would have been even more significant, ie, less 
obstruction and less EMT together.
Conclusion and summary
Our data provide evidence for active EMT in small as well as 
the previously demonstrated large airways of smokers with 
CAL. On the basis of Rbm hypervascularity, the EMT in large 
airways is characteristic of so-called Type-3 EMT, while 
Type-2 EMT is predominant in small airways. This is consis-
tent with the major pathologies in the two compartments: in 
large airways, the process might especially form a microen-
vironment for the development of lung cancer, while Type-2 
EMT is thought to be especially profibrotic and might be 
more related to small airway obstruction and obliteration. The 
relationship seen between the fibroblastic marker S100A4 and 
airflow obstruction would certainly fit with this.
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